Strategic Vision

  • MEGGA MIX is a food-derived oral antibody product under clinical development as a preventive intervention.
  • It is designed to target C. difficile bacteria locally in the gut while supporting microbial balance during and after antibiotic use.
  • Hospitals already integrate targeted nutritional and supportive interventions—MEGGA MIX can be incorporated into these protocols with minimal disruption.
  • The aim is to reduce the risk of CDI, minimize complications, and support safer, cost-efficient care for high-risk seniors.

Patient Experiences

I had taken antibiotics to treat my diverticulitis. A few weeks later I was having diarrhea and thought it was another bout. I gave a stool sample and was diagnosed with C. Diff, which I had never heard of. They gave me another antibiotic to treat this, which set off 8 months of 7 recurrent infections. I took Immunimed's oral antibody treatment and finally got better. It was simple to take and no side effects. If I'd known then what I know now about C. Diff and MEGGA MIX had been available, I would have taken it for sure.

– Michael B., C. diff survivor

I was given the antibiotic Amoxicillin/clavulanic Acid after laser prostate surgery in 2022. The pharmacist did note that C. Difficile could be a rare complication. Within days of completing the antibiotics, I developed severe cramping & diarrhea. I was now given another set of antibiotics to treat C. Diff. Unfortunately, several weeks later I again was suffering from C. Diff. Fortunately, I was put in contact with John Hare. He immediately had me enrolled in their phase 2 clinical trial treatment of Egg-derived polyclonal antibodies. In less than a week I was symptom free and the C. Diff never returned. Had I been given MEGGA MIX together with the initial antibiotics, I probably would have been spared the infection altogether, along with a lot of pain & discomfort. A preventive medicine for C. Difficile infection could be a life-saver.

– Bernie Falk, C. diff survivor

Individual experiences may vary. MEGGA MIX is currently under clinical investigation and is not FDA-approved for the prevention or treatment of C. difficile infection.